Unknown

Dataset Information

MEF2A is a transcription factor for circPVT1 and contributes to the malignancy of acute myeloid leukemia.


ABSTRACT: Acute myeloid leukemia (AML) is a hematological malignancy with a high relapse rate and a poor survival rate. The circular RNA circPVT1 and myocyte enhancer factor 2A (MEF2A) have unique functions in the progression of AML; however, the underlying mechanisms and clinical significance remain to be clarified. Bioinformatics and database analyses were used to assess the transcription factors and target genes of circPVT1. Dual‑luciferase reporter gene and argonaute 2‑RNA immunoprecipitation assays were used to verify the targeted relationships. The expression levels of related genes and proteins were detected by reverse transcription‑quantitative PCR and western blotting. Cell viability and apoptosis were detected by Cell Counting Kit‑8 assay and flow cytometry, respectively. The results revea

SUBMITTER: Wu K 

PROVIDER: S-EPMC11436260 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature